PubRank

Mark Larché

Author PubWeight™ 21.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am J Respir Crit Care Med 2003 2.46
2 Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009 1.73
3 Tregs and allergic disease. J Clin Invest 2004 1.64
4 The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood 2013 1.44
5 T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2005 1.24
6 Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J Allergy Clin Immunol 2011 1.23
7 Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study. J Allergy Clin Immunol 2012 1.07
8 Immunotherapy with peptides. Allergy 2011 1.07
9 The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J Immunol Methods 2006 1.03
10 Peptide-based vaccination: where do we stand? Curr Opin Allergy Clin Immunol 2005 0.84
11 Investigating T cell activation and tolerance in vivo: peptide challenge in allergic asthmatics. Cytokine 2004 0.81
12 Peptide-based vaccines in the treatment of specific allergy. Curr Drug Targets Inflamm Allergy 2002 0.81
13 Peptide-based immunotherapy: a novel strategy for allergic disease. Expert Rev Vaccines 2005 0.80
14 The potential of peptide immunotherapy in allergy and asthma. Curr Allergy Asthma Rep 2002 0.79
15 Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects. Thorax 2007 0.78
16 Immune mechanisms of sublingual immunotherapy: are oral Langerhans cells the masters of tolerance? J Allergy Clin Immunol 2010 0.78
17 Allergen immunotherapy with cat allergen peptides. Springer Semin Immunopathol 2003 0.78
18 T Lymphocyte responses to nonpolymorphic HLA-derived peptides are associated with chronic renal allograft dysfunction. Transplantation 2011 0.76
19 Peptide immunotherapy for allergic disease. Expert Opin Biol Ther 2003 0.76
20 Peptide therapy and asthma. Am J Respir Crit Care Med 2004 0.75
21 Chronic graft versus host disease is associated with an immune response to autologous human leukocyte antigen-derived peptides. Transplantation 2010 0.75